2 mg semaglutide The Ozempic Pill Has Arrived.
Description
Low blood glucose (blood sugar), especially if taken with certain diabetes medications
GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion while suppressing inappropriate glucagon release
Wegovy EPAR product information European Medicines Agency
And its not just in the States
Important uncertainties remain: rare adverse effects that require larger or longer studies to detect
Developed by Innovent Biologics, it is being evaluated in multiple phase 1 and phase 2 clinical trials for obesity, type 2 diabetes, and metabolic dysfunctionassociated fatty liver disease (MAFLD)
